American Testosterone Clinic for Men



Did Lower Testosterone Make The Modern Man? | WUNC


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minuteAbout 50,000 years ago, people started developing tools. They started making art, in caves. And they started cooperating. Simultaneously, that's when our faces went from looking like the skull on the left, to the one on the right. A group of researchers from Duke and the University of Utah are theorizing that the correlation is not coincidence - that, in fact, the changing shape of skulls signals a change in something else that would have made cooperation more likely: A drop in male testosterone levels. "Looking mostly at the brow ridges, the area above your eyes... and the shape of … Read more »

Testosterone in healthy men increases their brains' response to threat


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minutePUBLIC RELEASE DATE: 11-Aug-2014 Contact: Rhiannon Bugno Biol.Psych@utsouthwestern.edu 214-648-0880 Elsevier Philadelphia, PA, August 11, 2014 Testosterone, a steroid hormone, is well known to contribute to aggressive behavior in males, but the neural circuits through which testosterone exerts these effects have not been clear. Prior studies found that the administration of a single dose of testosterone influenced brain circuit function. Surprisingly, however, these studies were conducted exclusively in women. Researchers, led by Dr. Justin Carr, sought to rectify this gap by conducting a study of the effects of testosterone on the brain's response to threat cues in healthy men. They focused … Read more »

Did Reduced Testosterone Levels Help Human Culture Advance?


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesAugust 3, 2014 Image Caption: A composite image shows the facial differences between an ancient modern human with heavy brows and a large upper face and the more recent modern human who has rounder features and a much less prominent brow. The prominence of these features can be directly traced to the influence of the hormone testosterone. Credit: Robert Cieri, University of Utah redOrbit Staff & Wire Reports Your Universe Online Changes in the human skull occurring approximately 50,000 years ago indicate that the rise of culture occurred around the same time as a reduction in testosterone levels, according to … Read more »

New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesLos Angeles, CA (PRWEB) July 25, 2014 In recent years, men have become more aware of, willing to talk about, and eager to reverse the symptoms associated with age-related testosterone decline. Amid concerns about testosterone and heart health in the media at large, a new case study from Renew Man helps to shed light on the real benefits of testosterone therapy using bioidentical hormones. The case study centers around a patient named Jason, a 38-year-old father from Seattle who found himself beginning to feel the effects of age-related hormonal decline. Jason described himself as a skinny fatty, who at 511 … Read more »

FDA Requires Low-T Drug Manufacturers to Place Blood Clot Warning on Drugs


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesFDA Says Low-T Drug Manufacturers Must Warn of Blood Clot Risks Surely youve seen the commercials for low-t or low testosterone. If you havent, heres a glimpse: Clearly, low-t drug manufacturers promise a rejuvenated sex life and the commercials also seem to suggest that you will want to go sailing and walk along the beach. All joking aside, low-t drug treatment has been touted as a panacea for aging men, but it hasnt been until recently that warnings about possible blood clots from taking low-t drugs have come to the forefront. Naturally, low-t drug manufacturers probably dont want their potential … Read more »

Are Low-T medications worth the risk?


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minuteORLANDO, Fla. - Commercials touting the benefits of testosterone replacement therapy are all over the airwaves. And lately, commercials from law firms claiming testosterone therapy can harm you are dominating the airwaves as well. Several lawsuits filed nationwide by users of testosterone therapy gels have recently been consolidated through a federal court in Illinois, paving the way for the legal system to ultimately decide if testosterone therapy is safe, and if the testosterone therapy industry has been honest enough about the risks in its ads. Orlando's Morgan and Morgan law firm is one of many law firms advertising that "these … Read more »

Fitbit for Testosterone Junkies: Health-Tracking Gadgets Reach the Molecular Level


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 3 minutesThe experiment kicked off a year ago when Ayub Khattak, co-founder of the health-monitoring startup Cue, resolved to eat only quinoa, leafy greens, and the like. His business partner, Clint Sever, subsisted on fast food. Every day, four times a day, they measured themselves using their companys namesake device, which can gauge testosterone, the luteinizing hormone linked to female fertility, vitamin D, and inflammation. Cue also produces an accurate diagnosis of influenza. It was fascinating to see what happened, Khattak recalls of their one-month experiment, which coincided with an intense period of development for their startup. Their respective diets had … Read more »

Double Blessing For Trimel Pharma…


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minuteWednesday was a day of double blessing for Toronto-based Trimel Pharmaceuticals Corp. (TRL.TO: Quote) (TRLPF.OB), with the company reporting positive news related to regulatory decision as well as clinical trial results. As regards the regulatory decision, the company's Natesto testosterone nasal gel, an androgen indicated for replacement therapy in males with low testosterone, has received FDA approval. Natesto, formerly known as CompleoTRT, becomes the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone. According to the company, Natesto is self-administered via a nasal applicator thereby minimizing … Read more »

Northbrook oral testosterone drug maker plans IPO


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesA Northbrook-based developer of an oral testosterone drug plans an $86.2 million initial public offering, according to a Securities and Exchange Commission filing. Clarus Therapeutics Inc. had filed for an IPO in 2010 but withdrew its plan in 2011. The company plans to trade on NASDAQ under the symbol "CLRS." The company submitted a new-drug application in January for its oral testosterone replacement therapy to the Food and Drug Administration, Clarus was founded in 2003 and began operating in 2004. It doesnt have any products approved for sale, and, to date, hasnt generated any revenue. We do not expect to … Read more »

Is male menopause real?


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesPhoto: Getty Do fewer erections and less interest in sex sound familiar? We know mood swings, hot flushes, low libido and depression can be some of the hormonal changes older women experience during menopause, but what is not well known is that some men will experience some of the same symptoms when they get older. One of my favourite sayings is: "Male menopause is much more fun than female menopause. A female gains weight and gets hot flushes a male dates younger women and drives a sports car." The medical profession is still debating the existence of male menopause and … Read more »

The Battle Over Testosterone


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesIts a hugely profitable business. Helping guys to T it up has been making a few people very, very rich as an aging male population looks for quick and easy ways to preserve their youth and virility despite compelling evidence that taking such supplements unnecessarily can greatly increase the chances of stroke and heart attack. Already, professional sports regulators in two states have banned the use of testosterone, and studies have been published demonstrating the risks of testosterone replacement therapy among men who have no real medical need. Consumer advocate groups have asked the FDA to place black box warnings … Read more »

Senior Focus: Testosterone treatment questions


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesTestosterone use among men has increased significantly in recent years. Much of this increase is in response to doctors recommendations for treatment of symptomatic low testosterone levels, advertising of testosterone replacement therapy and the belief that low testosterone may increase the risk of developing cardiovascular disease (heart attack and stroke). Most recent studies that followed a population over time suggested that deficiencies in male hormones such as testosterone and dihydrotestosterone may increase the risk of cardiovascular disease. Because low testosterone is a potentially reversible condition, it makes some sense that hormone replacement would be a good idea to prevent cardiovascular … Read more »

BPH Patients Are Not Safe Taking Testosterone, While Dr. Allens Device Terminates Prostate Enlargement and Increases …


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesLondon, GB (PRWEB) May 03, 2014 Fine Treatment recommends that a man with benign prostatic hyperplasia (BPH) should use Dr. Allens Device in the first place, as it diminishes the enlarged prostate size naturally relieving lower urinary tract symptoms and increasing male energy. At the same time, commonly used to boost a man's energy testosterone, according to the article in the WWL-News, it is not safe, as it states: testosterone therapy in men with a high prevalence of cardiovascular diseases was stopped prematurely due to adverse cardiovascular events raising concerns about testosterone therapy safety. Dr. Harold Fuselier, urologist from the … Read more »

Low testosterone levels may indicate worsening of disease for men with prostate cancer


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesPUBLIC RELEASE DATE: 5-May-2014 Contact: Evelyn Martinez sciencenewsroom@wiley.com Wiley For men with low-risk prostate cancer, low levels of testosterone may indicate a worsening of their disease. That's the conclusion of a new study published in BJU International. The findings may help physicians identify patients with low-risk prostate cancer who should receive aggressive anticancer treatment. Men with prostate cancer that is not life threatening and is only slowly progressing, can often forego treatment and instead undergo active surveillance. This involves close monitoring to ensure that their disease does not become serious and jeopardize their health. Unfortunately, doctors currently have no reliable … Read more »

New Site Launched to Address Male Testosterone and Erectile Dysfunction Concerns


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minute(PRWEB) May 01, 2014 Two new sites have launched to address mens questions when it comes to low testosterone and erectile dysfunction: TestosteroneNYC.com and NJTestosterone.com. The sites were founded by Dr. Muhammad Mirza, a health practitioner in the New York and New Jersey area, and are designed to be a resource for men with low testosterone and erectile dysfunction. In his experience, men with these conditions can find it difficult and embarrassing to talk about, but they definitely have a lot of questions about the disorders and treatment options that are available. These new sites feature thorough and well-research blogs … Read more »

The Lancet Diabetes & Endocrinology: Large clinical trials to evaluate risks of testosterone treatment urgently needed


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesPUBLIC RELEASE DATE: 27-Apr-2014 Contact: Stephanie Page page@u.washington.edu The Lancet Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a Comment in The Lancet Diabetes & Endocrinology, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA. While the benefits of testosterone therapy in younger men with a deficiency of the hormone are well established, testosterone is now widely prescribed to older men, particularly in the USA. Existing studies have produced conflicting findings over whether the prescription of testosterone … Read more »

Acrux falls 15% on sales warning


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minuteMarkets Drug delivery company Acrux has warned it is at risk of missing its next milestone payment from distributor Eli Lilly because concerns about a potential link between testosterone replacement therapy and heart failure have hampered sales in the United States. Acrux's lead product is Axiron, a therapy to treat hypogonadism, a condition of low or no testosterone in men. In January the US Food and Drug Administration said it would investigate whether TRT increased the risk of heart attack and stroke in some men. The company and medical professionals have criticised the two studies upon which the FDA based … Read more »

Law Firm Investigates Cases of Testosterone Therapies


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: < 1 minuteBy Estel Grace Masangkay The Torkzadeh Law Firm announced it is currently investigating and accepting cases of possible injury, such as heart attack or stroke, resulting from the use of testosterone replacement therapies. Side effects of testosterone replacement therapy recently made headlines in the past few months, prompting an investigation from the U.S. Food and Drug Administration (FDA) in January. FDA is investigating the risk of stroke, heart attack, and death in men taking FDA-approved testosterone products At this time, FDA has not concluded that FDA-approved testosterone treatment increases the risk of stroke, heart attack, or death. Patients should not … Read more »

More Testing Before Determining Need for Testosterone Therapy Treatment?


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesHealth experts recommend that doctors perform a physical exam along with a blood test to determine whether or not a man needs testosterone therapy treatment. In a study to be published in the Journal Urology, a lack of consistency was found in laboratory practices resulting in inaccurate blood tests. The studys lead author, Dr. Paduch, said, In some cases, testosterone (T) levels, tested on the same day from a blood sample taken from a single patient, differed by as much as 30 percent from one lab to the next. How a Doctor Diagnoses a Patient with Low Testosterone A doctor … Read more »

Can testosterone shots prevent diabetes in men?


Posted by Dr. Michael White, Updated on May 4th, 2015

Reading Time: 2 minutesUniversity of Sydney researchers are seeking male participants for a novel trial assessing whether regular testosterone shots can prevent type 2 diabetes in men. The $4.8 million Testosterone for the prevention of Diabetes Mellitus (T4DM) study - the first of its kind in the world - is looking at the potential benefits of treating men with early signs of the condition (pre-diabetes) with testosterone supplements in conjunction with a dedicated weight-loss program. The researchers are seeking up to 1500 overweight male participants aged 50-74 for this ground-breaking study ranging across NSW, Victoria, South Australia and Western Australia. Lead investigator, Associate … Read more »